In addition, recent studies have confirmed that RUNX2 is closely related to the proliferation and invasion of cancers, such as osteosarcoma, breast cancer, prostate cancer, gastric cancer, lung cancer, melanoma, and colorectal cancer [11–13]. Here, RUNX2 is linked to prostate cancer.